Exploration of 2-deoxy-D-ribose and 17β-Estradiol as alternatives to exogenous VEGF to promote angiogenesis in tissue-engineered constructs

Regen Med. 2019 Mar;14(3):179-197. doi: 10.2217/rme-2018-0068. Epub 2019 Feb 22.

Abstract

Aim: In this study, we explored the angiogenic potential and proangiogenic concentration ranges of 2-deoxy-D-ribose (2dDR) and 17β-Estradiol (E2) in comparison with VEGF. The 2dDR and E2 were then loaded into tissue engineering (TE) scaffolds to investigate their proangiogenic potential when released from fibers. Materials & methods:Ex ovo chick chorioallantoic membrane (CAM) assay was used to evaluate angiogenic activity of 2dDR and E2. Both factors were then introduced into scaffolds via electrospinning to assess their angiogenic potential when released from fibers. Results: Both factors were approximately 80% as potent as VEGF and showed a dose-dependent angiogenic response. The sustained release of both agents from the scaffolds stimulated neovascularization over 7 days in the chorioallantoic membrane assay. Conclusion: We conclude that both 2dDR and E2 provide attractive alternatives to VEGF for the functionalization of tissue engineering scaffolds to promote angiogenesis in vivo.

Keywords: 2-deoxy-D-ribose; VEGF; angiogenesis; chick chorioallantoic membrane assay; estradiol.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chick Embryo
  • Chorioallantoic Membrane / blood supply*
  • Chorioallantoic Membrane / drug effects
  • Deoxyribose / pharmacology*
  • Estradiol / pharmacology*
  • Estrogens / pharmacology
  • Neovascularization, Physiologic / drug effects
  • Neovascularization, Physiologic / physiology*
  • Tissue Engineering / methods*
  • Vascular Endothelial Growth Factor A / pharmacology*

Substances

  • Estrogens
  • Vascular Endothelial Growth Factor A
  • Estradiol
  • Deoxyribose